Preliminary safety data relating to bladder cancer risk of Takeda’s Actos under review by US FDA; Actelion subpoenaed over Tracleer marketing


The US Food and Drug Administration says it has begun a safety review of Japanese drug major Takeda Pharmaceutical’s…

ActelionActosBiotechnologyDiabetesLegalNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTakeda PharmaceuticalsTracleer

Back to top